Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oosterhuis

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Immunological Methods|February 26, 1993
A simple optical fiber device for quantitative fluorescence microscopy of single living cellsM van Graft, B Oosterhuis, K O van der Werf, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose-dependent uricosuric effect of ambroxolB Oosterhuis, G Storm, P J Cornelissen, et al.
Biopharmaceutics & Drug Disposition|December 1, 1991
A combined single and multiple dose pharmacokinetic study of oral isosorbide-5-mononitrate in healthy volunteersG Storm, B Oosterhuis, J Bron, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Lack of pharmacokinetic interaction between vinpocetine and oxazepamG Storm, B Oosterhuis, F A Sollie, et al.
Journal of Chromatography. A|April 12, 1996
Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasmaJ Wieling, G Hendriks, W J Tamminga, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in manB Oosterhuis, R J ten Berge, H P Sauerwein, et al.
British Journal of Pharmacology|November 20, 2009
Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1A Dreiseitel, B Oosterhuis, K V Vukman, et al.
European Journal of Clinical Pharmacology|February 7, 2002
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteersW J Tamminga, J Wemer, B Oosterhuis, et al.
Biopharmaceutics & Drug Disposition|April 17, 2003
Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failureJ Barré, P Ledudal, B Oosterhuis, et al.
Journal of Clinical Pharmacology|March 24, 2006
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteersB Klem, G Lappin, S Nicholson, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|February 26, 1993
A simple optical fiber device for quantitative fluorescence microscopy of single living cellsM van Graft, B Oosterhuis, K O van der Werf, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose-dependent uricosuric effect of ambroxolB Oosterhuis, G Storm, P J Cornelissen, et al.
Biopharmaceutics & Drug Disposition|December 1, 1991
A combined single and multiple dose pharmacokinetic study of oral isosorbide-5-mononitrate in healthy volunteersG Storm, B Oosterhuis, J Bron, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Lack of pharmacokinetic interaction between vinpocetine and oxazepamG Storm, B Oosterhuis, F A Sollie, et al.
Journal of Chromatography. A|April 12, 1996
Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasmaJ Wieling, G Hendriks, W J Tamminga, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984
Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in manB Oosterhuis, R J ten Berge, H P Sauerwein, et al.
British Journal of Pharmacology|November 20, 2009
Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1A Dreiseitel, B Oosterhuis, K V Vukman, et al.
European Journal of Clinical Pharmacology|February 7, 2002
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteersW J Tamminga, J Wemer, B Oosterhuis, et al.
Biopharmaceutics & Drug Disposition|April 17, 2003
Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failureJ Barré, P Ledudal, B Oosterhuis, et al.
Journal of Clinical Pharmacology|March 24, 2006
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteersB Klem, G Lappin, S Nicholson, et al.
Pageof 6